Sustained release of nano-encapsulated glimepiride drug with chitosan nanoparticles: A novel approach to control type 2 diabetes in streptozotocin-induced Wistar albino rats
- 6 December 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138496
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Implantable sustained-release drug delivery systems: a revolution for ocular therapeuticsInternational Ophthalmology, 2023
- Novel Cytocompatible Chitosan Schiff Base Derivative as a Potent Antibacterial, Antidiabetic, and Anticancer AgentArabian Journal for Science and Engineering, 2023
- A novel quantitative assay for analysis of GLUT4 translocation using high content screeningBiomedicine & Pharmacotherapy, 2021
- Chitosan: A promising therapeutic agent and effective drug delivery system in managing diabetes mellitusCarbohydrate Polymers, 2020
- Prebiotics and Probiotics in Feed and Animal Health2019
- Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatmentCarbohydrate Polymers, 2018
- Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—An in vitro and in vivo approachCarbohydrate Polymers, 2017
- Synthesis and characterization of novel drug delivery system using modified chitosan based hydrogel grafted with cyclodextrinChemical Engineering Journal, 2016
- Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: Implication of different mechanism from pioglitazoneDiabetes Research and Clinical Practice, 2008
- Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-γ activity in 3T3-L1 adipocytesBiochemical and Biophysical Research Communications, 2005